Augment Therapy, Cleveland-based HealthTech startup, raises $2.7 million seed plus round
Lindsay Watson, Co-Founder at CEO of Augment Therapy
Augment Therapy, a Cleveland-based digital health startup, has raised a $2.7 million seed plus round from both current and new investors. The company creates rehabilitative healthcare through immersive and gamified technology.
The company is led by co-founder and CEO Lindsay Watson PT, MPT. Lindsay is a physical therapist by training that took her industry knowledge and launched Augment Therapy in January 2017.
What the company does
According to the company, "Augment Therapy’s augmented reality exercise technology can be used in various settings, from pediatric children’s hospitals servicing inpatient and outpatient care, to adult rehabilitation, and skilled nursing facilities to the home for general wellness users."
Investors include BlueTree Capital Group, CareSource, The Healthcare Collaboration Fund (jointly managed by JumpStart and University Hospital Ventures), VisionTech, and various angel investors.
Augment Therapy plans to use the funds to help grow the product line, deepen research validation, and increase market traction.
Why this matters to Ohio
Cleveland is a global leader in healthcare and a hub for cutting-edge medical innovation, research, and patient care. Increasing venture capital dollars into Ohio startups with deep industry expertise and knowledge, like Augment Therapy, will continue to put Ohio’s healthcare leadership on the map.
What they're saying
“In these challenging times of securing capital, we take pride in the unwavering support of our investors who share our mission and remain steadfast in their commitment to fueling our growth.”
- Lindsay Watson, PT, MPT, CEO and co-Founder of Augment Therapy
“Augment Therapy’s extended reality platform has redefined the physical therapy experience for many patients at University Hospitals Rainbow Babies & Children’s Hospital. Through the Healthcare Collaboration Fund, UH Ventures and JumpStart Ventures look forward to supporting the company’s expansion into new markets so as to enrich more experiences that can drive better health outcomes.”
- Matthew Zenker, Director, Deal Flow & Investments at UH Ventures